Skip to main content

BraineHealth Launches Diagnosio - a Building Block for a True Virtual Doctor

BraineHealth launches Diagnosio - a virtual doctor that proposes diagnoses based on your medical symptoms.



STOCKHOLM - July 17, 2018 - (Newswire.com)

The Swedish company BraineHealth that is developing automation tools for healthcare using AI methods has launched Diagnosio.

Diagnosio is a virtual doctor that proposes diagnoses from patient data such as age, gender and patient symptoms.

The virtual doctor app Diagnosio can be used by patients to their own discretion but is also preferably used together with a family doctor.

Diagnosio is a virtual doctor that proposes diagnoses based on the patient's vital medical information such as their symptoms, age, and gender. The app Diagnosio proposes a structured top 10 list of potential diagnoses and then suggests additional information provided by trusted medical knowledge sources. 

The proposed diagnoses are made by a relevant match between patient data and potential diagnoses based on deep learning from thousands of diagnoses and millions of previous symptom queries using artificial intelligence.

When needed, Diagnosio will alert the user to seek immediate medical advice for some of the proposed diagnoses.

For each and every proposed diagnosis, Diagnosio will provide the user with links to trusted medical knowledge sources such as Merck Consumer database, Medline Plus, Mayo Clinic, WebMD, and popular search engines.

Anyone can sign up for a free trial account, without having to add any payment information. Diagnosio also offers a wide array of Subscriptions tiers, modified for different family structures. By using Diagnosio, you agree to the Terms and Services.

Media Contact: 
Roger Svensson
Phone: +46 70 799 28 96
Email: roger.svensson@brainehealth.com


Related Links
Diagnoser Personal
Diagnoser Apps

Related Images




Press Release Service by Newswire.com

Original Source: BraineHealth Launches Diagnosio - a Building Block for a True Virtual Doctor
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.